Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Autoimmune reactions may cause both alopecia areata and HAM.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

Adding Y-27632 and bFGF to the culture medium greatly improves goat hair follicle stem cell growth and quality.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Nilotinib can cause generalized keratosis pilaris.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

The rash resolved after stopping ponatinib.

Imatinib can cause hair loss due to lichen planopilaris.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Nilotinib can cause keratosis pilaris, a skin condition.